RMD Q1 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.1B+16.0% YoY

Gross Profit

$600M54.4% margin

Operating Income

$289M26.2% margin

Net Income

$219M19.9% margin

EPS (Diluted)

$1.49

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$286M

Free Cash Flow

$245M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$6.7B

Total Liabilities

$2.5B

Stockholders' Equity

$4.3B

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$950M	+16.0%
Gross Profit	$600M	$541M	+11.0%
Operating Income	$289M	$276M	+4.8%
Net Income	$219M	$210M	+4.2%

Revenue Segments

Sleep And Respiratory

$963M87%

Software As Service

$139M13%

Geographic Segments

Us Canada And Latin America

$638M66%

Combined Europe Asia And Other Markets

$325M34%